1. Taiwan Stocks

  2. •

    Health services

  3. •

    Medical/Nursing services
Avita Corporation

Avita Corporation

TTPEX:4735
36.35
TWD
-0.40
(-1.09%)
5.99EPS
5.21P/E
1.20BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
20.33
26.58
33.8
32.53
34.82
40.94
39.82
73
63.47
32.53
23.91
25.9
24.68
25.16
Basic EPS, GAAP
-1.09
0.91
1.96
2.47
3.17
3.05
4.18
14.6
8.61
2.74
1.16
1.62
2.46
5.99
Free Cash Flow per Basic Share
-0.38
-3.75
2.03
3.73
1.26
2.3
5.97
5.85
4.51
11.52
4.92
3.04
-5.21
-3.63
Dividend per Share
- -
- -
0.38
1.17
2
2.25
2.29
8.9
8.16
2.49
1.49
0.43
2.36
1.1
Book Value per Share
11.05
11.13
13.89
13.11
13.67
13.48
16.56
23.97
25.79
24.69
24.17
24.12
25.87
29.36
Tangible Book Value per Share
10.92
11.02
13.82
13.06
13.62
13.43
16.53
23.94
25.76
24.64
24.1
24.07
25.83
29.33
Basic Weighted Avg Shares
29
29
31
34
33
32
31
36
37
37
37
36
38
39
Sales/Revenue/Turnover
586
782
1,057
1,101
1,135
1,327
1,248
2,600
2,325
1,201
879
927
936
973
Operating Margin (%)
-10.73
0.41
8.05
10.99
10.2
9.81
14.17
25.55
16.81
9.7
1.65
1.68
4.95
5.55
Depreciation Expense
19
21
20
22
22
27
33
43
72
69
61
67
60
57
Net Income, GAAP
-31
27
61
84
103
99
131
520
315
101
43
58
93
232
Effective Tax Rate (%)
- -
18.3
21.66
13.76
15.36
20.22
22.24
19.86
19.4
25.93
- -
- -
0.52
4.27
Profit Margin (%)
-5.36
3.41
5.81
7.6
9.1
7.45
10.5
20
13.57
8.42
4.86
6.24
9.95
23.8
Working Capital
200
236
260
271
133
297
333
362
415
429
430
368
320
388
LT Debt
143
103
33
61
45
218
191
10
1
2
2
- -
- -
6
Total Equity
319
341
424
449
445
423
525
909
952
911
888
838
996
1,131
Return on Invested Capital (%)
- -
0.52
13.06
19.98
15.74
14.47
18.64
47.4
22.79
7.55
- -
- -
4.85
4.44
Return on Capital (%)
- -
6.08
12.95
16.64
17.17
14.58
18.71
49.37
24.21
9.13
- -
- -
9.88
20.06
Return on Common Equity (%)
-9.35
8.08
16.05
19.17
23.08
22.77
27.62
72.49
33.9
10.86
4.75
6.7
10.16
22.63

Capital Structure

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
32
124
256
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
7
6
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
39
39
39
Market Capitalization
1,236
1,192
1,201

Working Capital

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
675
805
1,052
Cash, Cash Equivalents & STI
433
491
687
Accounts Receivable, Net
78
83
122
Inventories
88
121
162
Total Current Liabilities
356
480
664
Payables & Accruals
- -
- -
- -
ST Debt
32
124
256
Deferred Revenue
- -
- -
- -

Growth Rates

TWD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
10.83%
2.22%
18.84%
Free Cash Flow
3.32%
-48.48%
-281.82%
Net Income, GAAP
31.64%
-13.71%
61.01%
Sales/Revenue/Turnover
4.73%
-15.85%
0.98%
Total Cash Common Dividend
93.59%
57.76%
475.69%

Quarterly Revenue

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
195
254
269
209
927
2025
199
254
236
248
936
2026
215
273
- -
- -
- -

Quarterly Earnings Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.15
0.62
0.56
0.6
1.62
2025
0.29
0.51
0.9
0.73
2.46
2026
1.19
3.18
- -
- -
- -

Quarterly Dividends Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.43
2025
- -
- -
0.39
0.7
2.36
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Chyang Jih
Full Time Employees
84
Sector
Health services
Industry
Medical/Nursing services
Address
No.78, Kwang-Fu Road New Taipei TP Taiwan 24158
IPO Date
Aug 16, 2011
Website
avita.com.tw
Similar Companies
Hims & Hers Health, Inc. (NYSE:HIMS)
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Mobile-health Network Solutions (NASDAQ:MNDR)
Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
Tenon Medical, Inc. (NASDAQ:TNON)
Teladoc Health, Inc. (NYSE:TDOC)
Business
AViTA Corporation (4735.TWO) manufactures and sells home healthcare and point-of-care medical devices, specializing in OEM/ODM solutions for clinical and personal use; its core products include non-contact infrared thermometers, infrared ear/forehead thermometers, infrared ear thermometers, wrist-type and arm-type blood pressure monitors, electronic nasal aspirators, nebulizers, electronic breast pumps, pulse oximeters, and electronic lice combs. Founded in 1996 and headquartered in New Taipei City, Taiwan, the company operates primarily in the medical devices sector, serving markets in the United States, Europe, Asia, and other regions through export-focused sales. AViTA maintains subsidiaries for material procurement and emphasizes in-house R&D with certifications including GMP, FDA approval, CE marking, and ISO 13485. In recent developments, AViTA completes its "four major domains and five new products" strategy encompassing nebulizers (NE10, NE60), pulse oximeters (SP61), electronic breast pumps (BR10), and electronic lice combs, alongside integrating thermometer and blood pressure monitor lines into the supply chain of Japanese firm Omron with shipments commencing in China, Southeast Asia, and Europe in 2025's third quarter; these initiatives drive projected second-half 2025 revenue and profitability exceeding the first half, with new growth acceleration in 2026 and potential expansion in 2027.